Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 3
1987 2
1988 3
1989 2
1990 2
1991 3
1993 3
1994 6
1995 2
1996 7
1997 4
1998 6
1999 6
2000 4
2001 11
2002 11
2003 16
2004 10
2005 8
2006 8
2007 12
2008 14
2009 10
2010 10
2011 14
2012 16
2013 15
2014 15
2015 17
2016 19
2017 26
2018 13
2019 21
2020 30
2021 21
2022 14
Text availability
Article attribute
Article type
Publication date

Search Results

358 results
Results by year
Filters applied: . Clear all
Page 1
What turns CREB on? And off? And why does it matter?
Steven A, Friedrich M, Jank P, Heimer N, Budczies J, Denkert C, Seliger B. Steven A, et al. Among authors: seliger b. Cell Mol Life Sci. 2020 Oct;77(20):4049-4067. doi: 10.1007/s00018-020-03525-8. Epub 2020 Apr 28. Cell Mol Life Sci. 2020. PMID: 32347317 Free PMC article. Review.
LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells.
Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A, Matos C, Bruss C, Klobuch S, Peter K, Kastenberger M, Bogdan C, Schleicher U, Mackensen A, Ullrich E, Fichtner-Feigl S, Kesselring R, Mack M, Ritter U, Schmid M, Blank C, Dettmer K, Oefner PJ, Hoffmann P, Walenta S, Geissler EK, Pouyssegur J, Villunger A, Steven A, Seliger B, Schreml S, Haferkamp S, Kohl E, Karrer S, Berneburg M, Herr W, Mueller-Klieser W, Renner K, Kreutz M. Brand A, et al. Among authors: seliger b. Cell Metab. 2016 Nov 8;24(5):657-671. doi: 10.1016/j.cmet.2016.08.011. Epub 2016 Sep 15. Cell Metab. 2016. PMID: 27641098 Free article.
NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis.
Glasner A, Levi A, Enk J, Isaacson B, Viukov S, Orlanski S, Scope A, Neuman T, Enk CD, Hanna JH, Sexl V, Jonjic S, Seliger B, Zitvogel L, Mandelboim O. Glasner A, et al. Among authors: seliger b. Immunity. 2018 Jan 16;48(1):107-119.e4. doi: 10.1016/j.immuni.2017.12.007. Epub 2018 Jan 9. Immunity. 2018. PMID: 29329948 Free article.
PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer.
Stein A, Simnica D, Schultheiß C, Scholz R, Tintelnot J, Gökkurt E, von Wenserski L, Willscher E, Paschold L, Sauer M, Lorenzen S, Riera-Knorrenschild J, Depenbusch R, Ettrich TJ, Dörfel S, Al-Batran SE, Karthaus M, Pelzer U, Waberer L, Hinke A, Bauer M, Massa C, Seliger B, Wickenhauser C, Bokemeyer C, Hegewisch-Becker S, Binder M. Stein A, et al. Among authors: seliger b. J Immunother Cancer. 2021 Jul;9(7):e002844. doi: 10.1136/jitc-2021-002844. J Immunother Cancer. 2021. PMID: 34315821 Free PMC article. Clinical Trial.
Basis of PD1/PD-L1 Therapies.
Seliger B. Seliger B. J Clin Med. 2019 Dec 8;8(12):2168. doi: 10.3390/jcm8122168. J Clin Med. 2019. PMID: 31817953 Free PMC article. Review.
Immunotherapy of Breast Cancer.
Seliger B. Seliger B. Breast Care (Basel). 2018 Mar;13(1):5-6. doi: 10.1159/000486927. Epub 2018 Feb 13. Breast Care (Basel). 2018. PMID: 29950960 Free PMC article. No abstract available.
Opinion: Standardizing gene product nomenclature-a call to action.
Fujiyoshi K, Bruford EA, Mroz P, Sims CL, O'Leary TJ, Lo AWI, Chen N, Patel NR, Patel KP, Seliger B, Song M, Monzon FA, Carter AB, Gulley ML, Mockus SM, Phung TL, Feilotter H, Williams HE, Ogino S. Fujiyoshi K, et al. Among authors: seliger b. Proc Natl Acad Sci U S A. 2021 Jan 19;118(3):e2025207118. doi: 10.1073/pnas.2025207118. Proc Natl Acad Sci U S A. 2021. PMID: 33408252 Free PMC article. No abstract available.
TAP off--tumors on.
Seliger B, Maeurer MJ, Ferrone S. Seliger B, et al. Immunol Today. 1997 Jun;18(6):292-9. doi: 10.1016/s0167-5699(97)01052-9. Immunol Today. 1997. PMID: 9190116 Review. No abstract available.
358 results